Learn how a team of dedicated clinicians brought pulmonary thromboendarterectomy to Virginia.
Category: Heart & Vascular Excellence (Page 3)
A recent study of heart failure patients at UVA Health revealed that colchicine, a common gout medication, significantly improved survival rates.
We're using Leducq grants to push understanding of atherosclerosis into new realms.
One of only 15 healthcare centers in the country with the expertise to treat FMD effectively, UVA Health Heart & Vascular is contributing to research efforts that could lead to new therapies for this complex and serious disease.
UVA Health is among the few high-volume cardiac care centers in the country with the requisite skills and dedicated expertise to tackle chronic total occlusion. Find out how we achieve high success rates and life-changing outcomes.
The Virginia Congenital Cardiac Collaborative aims to optimize care and outcomes for children in Virginia with complex congenital heart defects.
Serving as a quaternary referral center, we give patients access to innovative procedures and devices only available at select centers.
Hypertrophic cardiomyopathy has historically been less well-understood than other cardiac conditions, but research at UVA Health is opening the door to tailored interventions.
UVA presented live cases at the premier TVT Conference, including a new technique for patients who can’t be helped by standard treatment.
Researchers at UVA Health developed a new heart function measurement that could significantly reduce deaths and hospitalizations from systolic heart failure and pulmonary hypertension.